P16227 AF NFT

Urokinase-type plasminogen activator

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihjvxrfclbyu2rsqzx75ssaqunmn4cebfihny5lzitkjrpgupohxy/metadata.json
IPFS of structure file: 
bafybeia5boemxw4d5d57q4qrap4exj5z4v4prdu4ffzxs72riauxc4pr6e/AF-P16227-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x88619Af48ae27e0a14d5caEcee59E5Cc8a1B0DB1
First NFT owner address (bech32): 
genesis13pse4ay2uflq59x4etkwuk09ej9pkrd3avh0u7
Current NFT ID #492561 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
492561
Accession (UniProt):
P16227
Name::
Urokinase-type plasminogen activator
Experimental Method:
Predicted structure
Sequence source:
PAPIO CYNOCEPHALUS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P16227 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P16227|UROK_PAPCY Urokinase-type plasminogen activator OS=Papio cynocephalus OX=9556 GN=PLAU PE=2 SV=1 MRALLAHLLLCVLVVSASKGSRELQVPSDCGCLNGGTCMSNKYFSSIHWCNCPKKFGGQHCEIDKSKTCYEGNGHFYRGKASTDTMGRSCLAWNSATVLQQTYHAHRSDALQLGLGKHNYCRNPDNRRRPWCYVQVGLKQRVQECMVHNCADGKKPSSPPEELQFQCGQRTLRPRFKIVGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVVSATHCFINYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHEDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPNDPPFGTSCEITGFGKENSTDYLYPEQLKMTVVKLVSHQKCQQPHYYGSEVTTKMLCAADPQWETDSCQGDSGGPLVCSIQGHMTLTGIVSWGRGCALKDKPGVYTRVSRFLPWIHSHTREQNGLAL